2013-2028 Report on Global Vaccine Adjuvants Market by Player, Region, Type, Application and Sales Channel

Published: Nov, 2018 | Pages: 119 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global vaccine adjuvants market is expected to display higher growth rate over the next ten years. Rapid surge in this market is credited to the high-end demand for effective and low cost vaccines. Growing prevalence of infectious diseases & zoonotic disorders, ever-increasing geriatric population, rising vulnerability towards genetic diseases, and rising number of resistant pathogens are expected to drive market demand for vaccine adjuvants in the upcoming years. Globally, vaccine adjuvants market is predicted to generate massive revenue over the next decade, providing numerous opportunities for industry participants to invest in research and development of vaccine adjuvants.

Additionally, higher approval rate by local & international organization in veterinary sector owing to the proven long lasting results of vaccine adjuvants and higher performance in comparison with the traditional vaccines are likely positively affect market growth.  Soaring demand for advanced analytical techniques for treatment of infectious diseases & zoonotic disorders is predicted to favor market growth in the upcoming years. In addition, surging need for fewer intrusive surgeries and introduction of disposable instruments is projected to foster the growth of vaccine adjuvants market over the forecast period.  

The recent technological advancement coupled with development of the novel products & techniques such as new vaccine antigens are expected to provide platform for the sustained growth of vaccine adjuvants market in the upcoming years. An adjuvant is termed as antigen, which is derived to improve capability of vaccine to induce protection against infection. Thus, adjuvants are typically added to vaccines in order to amplify their capability to influence long-term protection and safety against any kind of infections.

The vaccine adjuvants market is broadly categorized into major segments based on the product type such as adjuvant emulsions, pathogen components, combination adjuvants, and particulate adjuvants. Adjuvant emulsions segment is growing rapidly in this market with substantial revenue generation in the last few years. Growing popularity of adjuvant emulsions segment is attributed to the increasing product penetration and growing preference by healthcare professionals.

This market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in implementation of latest technologies in pharmaceutical & medicine sector, surge in number of research & development activities and existence of well-established healthcare infrastructure in the region. In European region, Germany, France, and United Kingdom are projected to witness steady growth. 

Asia-Pacific region is estimated to hold a major share in the vaccine adjuvants market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with strong economic growth, rising healthcare spending by local governments, rapid advancement in healthcare sector, and significant investment by leading industry players considering potential growth opportunities in the region.

The key players in the vaccine adjuvants market are Adjuvance Technologies Inc., Adjuvatis Corp., Brenntag AG, 	Chemtrade Logistics Inc., GlaxoSmithKline plc, Invivogen, Inc., Merck KGaA, Novavax, Inc., Oz Biosciences Co., Seppic (Air Liquide) Co., and Vaxliant, LLC.

The global Vaccine Adjuvants market was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028.

This report provides detailed historical analysis of global market for Vaccine Adjuvants from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Vaccine Adjuvants market.

Leading players of Vaccine Adjuvants including:

•	SEPPIC
•	SDA BIO
•	Brenntag Biosector
•	SPI Pharma
•	MVP Laboratories
•	Tj Kaiwei
•	Novavax
•	Zhuoyue
•	Aphios
•	GSK
•	CSL Limited
•	Avanti Polar Lipids

Market split by Type, can be divided into:

•	Oral
•	Subcutaneous
•	Intramuscular
•	Others

Market split by Application, can be divided into:

•	Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
•	Human Vaccine Adjuvants (Research Applications, Commercial Applications)

Market split by Sales Channel, can be divided into:

•	Direct Channel
•	Distribution Channel

Market segment by Region/Country including:

•	North America (United States, Canada and Mexico)
•	Europe (Germany, UK, France, Italy, Russia and Spain etc.)
•	Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
•	South America Brazil, Argentina, Colombia and Chile etc.)
•	Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

 Table of Contents

Chapter 1 Vaccine Adjuvants Market Overview
    1.1 Vaccine Adjuvants Definition
    1.2 Global Vaccine Adjuvants Market Size Status and Outlook (2013-2028)
    1.3 Global Vaccine Adjuvants Market Size Comparison by Region (2013-2028)
    1.4 Global Vaccine Adjuvants Market Size Comparison by Type (2013-2028)
    1.5 Global Vaccine Adjuvants Market Size Comparison by Application (2013-2028)
    1.6 Global Vaccine Adjuvants Market Size Comparison by Sales Channel (2013-2028)
    1.7 Vaccine Adjuvants Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)

Chapter 2 Vaccine Adjuvants Market Segment Analysis by Player
    2.1 Global Vaccine Adjuvants Sales and Market Share by Player (2016-2018)
    2.2 Global Vaccine Adjuvants Revenue and Market Share by Player (2016-2018)
    2.3 Global Vaccine Adjuvants Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player

Chapter 3 Vaccine Adjuvants Market Segment Analysis by Type
    3.1 Global Vaccine Adjuvants Market by Type
        3.1.1 Oral
        3.1.2 Subcutaneous
        3.1.3 Intramuscular
        3.1.4 Others
    3.2 Global Vaccine Adjuvants Sales and Market Share by Type (2013-2018)
    3.3 Global Vaccine Adjuvants Revenue and Market Share by Type (2013-2018)
    3.4 Global Vaccine Adjuvants Average Price by Type (2013-2018)
    3.5 Leading Players of Vaccine Adjuvants by Type in 2017
    3.6 Conclusion of Segment by Type

Chapter 4 Vaccine Adjuvants Market Segment Analysis by Application
    4.1 Global Vaccine Adjuvants Market by Application
        4.1.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
        4.1.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
    4.2 Global Vaccine Adjuvants Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Vaccine Adjuvants by Application in 2017
    4.4 Conclusion of Segment by Application

Chapter 5 Vaccine Adjuvants Market Segment Analysis by Sales Channel
    5.1 Global Vaccine Adjuvants Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Vaccine Adjuvants Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Vaccine Adjuvants by Sales Channel in 2017
    5.4 Conclusion of Segment by Sales Channel

Chapter 6 Vaccine Adjuvants Market Segment Analysis by Region
    6.1 Global Vaccine Adjuvants Market Size and CAGR by Region (2013-2028)
    6.2 Global Vaccine Adjuvants Sales and Market Share by Region (2013-2018)
    6.3 Global Vaccine Adjuvants Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Vaccine Adjuvants Market Share by Type
        6.4.3 North America Vaccine Adjuvants Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Vaccine Adjuvants Market Share by Type
        6.5.3 Europe Vaccine Adjuvants Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Vaccine Adjuvants Market Share by Type
        6.6.3 Asia-Pacific Vaccine Adjuvants Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Vaccine Adjuvants Market Share by Type in 2017
        6.7.3 South America Vaccine Adjuvants Market Share by Application in 2017
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Vaccine Adjuvants Market Share by Type
        6.8.3 Middle East & Africa Vaccine Adjuvants Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Vaccine Adjuvants Players
    7.1 SEPPIC
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 SDA BIO
    7.3 Brenntag Biosector
    7.4 SPI Pharma
    7.5 MVP Laboratories
    7.6 Tj Kaiwei
    7.7 Novavax
    7.8 Zhuoyue
    7.9 Aphios
    7.10 GSK
    7.11 CSL Limited
    7.12 Brenntag Biosector
    7.13 SEPPIC
    7.14 SPI Pharma
    7.15 Novavax
    7.16 Avanti Polar Lipids
    7.17 Aphios

Chapter 8 Upstream and Downstream Analysis of Vaccine Adjuvants
    8.1 Industrial Chain of Vaccine Adjuvants
    8.2 Upstream of Vaccine Adjuvants
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Vaccine Adjuvants
        8.3.1 Leading Distributors/Dealers of Vaccine Adjuvants
        8.3.2 Leading Consumers of Vaccine Adjuvants

Chapter 9 Development Trend of Vaccine Adjuvants (2018-2028)
    9.1 Global Vaccine Adjuvants Market Size (Sales and Revenue) Forecast (2018-2028)
    9.2 Global Vaccine Adjuvants Market Size and CAGR Forecast by Region (2018-2028)
    9.3 Global Vaccine Adjuvants Market Size and CAGR Forecast by Type (2018-2028)
    9.4 Global Vaccine Adjuvants Market Size and CAGR Forecast by Application (2018-2028)
    9.5 Global Vaccine Adjuvants Market Size Forecast by Sales Channel (2018-2028)

Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

List of Tables and Figures

    Figure Vaccine Adjuvants Example
    Figure Global Vaccine Adjuvants Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global Vaccine Adjuvants Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global Vaccine Adjuvants Sales Comparison by Type (2013-2028)
    Figure Global Vaccine Adjuvants Sales Comparison by Application (2013-2028)
    Figure Global Vaccine Adjuvants Sales Comparison by Sales Channel (2013-2028)
    Table Global Vaccine Adjuvants Sales by Player (2016-2018)
    Table Global Vaccine Adjuvants Sales Market Share by Player (2016-2018)
    Figure Global Vaccine Adjuvants Sales Market Share by Player in 2017
    Table Global Vaccine Adjuvants Revenue (Million $) by Player (2016-2018)
    Table Global Vaccine Adjuvants Revenue Market Share by Player (2016-2018)
    Figure Global Vaccine Adjuvants Revenue Market Share by Player in 2017
    Table Global Vaccine Adjuvants Average Price by Player (2016-2018)
    Figure Global Vaccine Adjuvants Average Price by Player in 2017
    Figure Global Vaccine Adjuvants Players Competition Situation - Top 5 Players' Revenue Market Share in 2017
    Figure Global Vaccine Adjuvants Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Oral
    Figure Global Oral Sales and Growth Rate (2013-2018)
    Figure Example of Subcutaneous
    Figure Global Subcutaneous Sales and Growth Rate (2013-2018)
    Figure Example of Intramuscular
    Figure Global Intramuscular Sales and Growth Rate (2013-2018)
    Figure Example of Others
    Figure Global Others Sales and Growth Rate (2013-2018)
    Table Global Vaccine Adjuvants Sales by Type (2013-2018)
    Table Global Vaccine Adjuvants Sales Market Share by Type (2013-2018)
    Figure Global Vaccine Adjuvants Sales Market Share by Type in 2017
    Table Global Vaccine Adjuvants Revenue (Million $) by Type (2013-2018)
    Table Global Vaccine Adjuvants Revenue Market Share by Type (2013-2018)
    Figure Global Vaccine Adjuvants Revenue Market Share by Type in 2017
    Table Global Vaccine Adjuvants Average Price by Type (2013-2018)
    Figure Global Vaccine Adjuvants Average Price by Type in 2017
    Table Leading Players of Vaccine Adjuvants by Type in 2017
    Figure Example of Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
    Figure Global Vaccine Adjuvants for Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Sales and Growth Rate (2013-2018)
    Figure Example of Human Vaccine Adjuvants (Research Applications, Commercial Applications)
    Figure Global Vaccine Adjuvants for Human Vaccine Adjuvants (Research Applications, Commercial Applications) Sales and Growth Rate (2013-2018)
    Table Global Vaccine Adjuvants Sales by Application (2013-2018)
    Table Global Vaccine Adjuvants Sales Market Share by Application (2013-2018)
    Figure Global Vaccine Adjuvants Sales Market Share by Application in 2017
    Table Leading Consumers of Vaccine Adjuvants by Application in 2017
    Figure Example of Direct Channel
    Figure Global Vaccine Adjuvants for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global Vaccine Adjuvants for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global Vaccine Adjuvants Sales by Sales Channel (2013-2018)
    Table Global Vaccine Adjuvants Sales Market Share by Sales Channel (2013-2018)
    Figure Global Vaccine Adjuvants Sales Market Share by Sales Channel in 2017
    Table Leading Distributors/Dealers of Vaccine Adjuvants by Sales Channel in 2017
    Table Global Vaccine Adjuvants Market Size and CAGR by Region (2013-2028)
    Table Global Vaccine Adjuvants Sales by Region (2013-2018)
    Table Global Vaccine Adjuvants Sales Market Share by Region (2013-2018)
    Figure Global Vaccine Adjuvants Sales Market Share by Region in 2017
    Table Global Vaccine Adjuvants Revenue (Million $) by Region (2013-2018)
    Table Global Vaccine Adjuvants Revenue Market Share by Region (2013-2018)
    Figure Global Vaccine Adjuvants Revenue Market Share by Region in 2017
    Table North America Vaccine Adjuvants Sales by Country (2013-2018)
    Figure North America Vaccine Adjuvants Sales Market Share by Country (2013-2018)
    Table North America Vaccine Adjuvants Revenue by Country (2013-2018)
    Figure North America Vaccine Adjuvants Revenue Market Share by Country (2013-2018)
    Figure North America Vaccine Adjuvants Sales Market Share by Type in 2017
    Figure North America Vaccine Adjuvants Sales Market Share by Application in 2017
    Figure United States Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure United States Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Canada Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Mexico Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe Vaccine Adjuvants Sales by Country (2013-2018)
    Figure Europe Vaccine Adjuvants Sales Market Share by Country (2013-2018)
    Table Europe Vaccine Adjuvants Revenue by Country (2013-2018)
    Figure Europe Vaccine Adjuvants Revenue Market Share by Country (2013-2018)
    Figure Europe Vaccine Adjuvants Sales Market Share by Type in 2017
    Figure Europe Vaccine Adjuvants Sales Market Share by Application in 2017
    Figure Germany Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Germany Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure UK Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure France Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure France Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Italy Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Russia Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Spain Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific Vaccine Adjuvants Sales by Country (2013-2018)
    Figure Asia-Pacific Vaccine Adjuvants Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Vaccine Adjuvants Revenue by Country (2013-2018)
    Figure Asia-Pacific Vaccine Adjuvants Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific Vaccine Adjuvants Sales Market Share by Type in 2017
    Figure Asia-Pacific Vaccine Adjuvants Sales Market Share by Application in 2017
    Figure China Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure China Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Japan Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Korea Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure India Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure India Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Southeast Asia Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Australia Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Table South America Vaccine Adjuvants Sales by Country (2013-2018)
    Figure South America Vaccine Adjuvants Sales Market Share by Country (2013-2018)
    Table South America Vaccine Adjuvants Revenue by Country (2013-2018)
    Figure South America Vaccine Adjuvants Revenue Market Share by Country (2013-2018)
    Figure South America Vaccine Adjuvants Sales Market Share by Type in 2017
    Figure South America Vaccine Adjuvants Sales Market Share by Application in 2017
    Figure Brazil Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Brazil Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Argentina Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Colombia Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Chile Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa Vaccine Adjuvants Sales by Country (2013-2018)
    Figure Middle East & Africa Vaccine Adjuvants Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Vaccine Adjuvants Revenue by Country (2013-2018)
    Figure Middle East & Africa Vaccine Adjuvants Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa Vaccine Adjuvants Sales Market Share by Type in 2017
    Figure Middle East & Africa Vaccine Adjuvants Sales Market Share by Application in 2017
    Figure Egypt Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Egypt Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure South Africa Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria Vaccine Adjuvants Sales and Growth Rate (2013-2018)
    Figure Nigeria Vaccine Adjuvants Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of SEPPIC
    Table Vaccine Adjuvants Introduction of SEPPIC
    Table Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share of SEPPIC (2016-2018)
    Table Industrial Chain of Vaccine Adjuvants
    Table Manufacturing Cost Structure of Vaccine Adjuvants
    Table General Manufacturing Process of Vaccine Adjuvants
    Table Leading Distributors/Dealers of Vaccine Adjuvants
    Table Leading Consumers of Vaccine Adjuvants
    Figure Global Vaccine Adjuvants Sales and Growth Rate Forecast (2018-2028)
    Figure Global Vaccine Adjuvants Revenue and Growth Rate Forecast (2018-2028)
    Table Global Vaccine Adjuvants Market Size and CAGR Forecast by Region (2018-2028)
    Table Global Vaccine Adjuvants Market Size and CAGR Forecast by Type (2018-2028)
    Table Global Vaccine Adjuvants Market Size and CAGR Forecast by Application (2018-2028)
    Table Global Vaccine Adjuvants Market Size and CAGR Forecast by Sales Channel (2018-2028)